Communicable Disease Control and Health Protection Handbook

The essential guide to controlling and managing today’s communicable diseases

The fourth edition of Communicable Disease Control and Health Protection Handbook offers public health workers of all kinds an authoritative and up-to-date guide to current protocols surrounding the identification and control of infectious diseases. With its concise, accessible design, the book is a practical tool that can be relied upon to explain topics ranging from the basic principles of communicable disease control to recent changes and innovations in health protection practice. Major syndromes and individual infections are insightfully addressed, while the authors also outline the WHO’s international health regulations and the organizational arrangements in place in all EU nations.

New to the fourth edition are chapters on Ebola, the Zika virus, and other emerging pandemics. In addition, new writing on healthcare-associated infection, migrant and refugee health, and the importance of preparedness make this an essential and relevant text for all those in the field. This vital resource:   

    Reflects recent developments in the science and administration of health protection practice
    Covers topics such as major syndromes, control of individual infections, main services and activities, arrangements for all European countries, and much more
    Includes new chapters on the Zika virus, Schistosomiasis, Coronavirus including MERS + SARS, and Ebola
    Follows a format designed for ease of use and everyday consultation

Created to provide public and environmental health practitioners, physicians, epidemiologists, infection control nurses, microbiologists and trainees with a straightforward – yet informative – resource, Communicable Disease Control and Health Protection Handbook is a practical companion for all those working the field today.

CONTENTS

Section 1: Introduction

1. How to use this book

2. Basic concepts in epidemiology of infectious disease

3. Basic concepts in the prevention of infection

4. Emergency risk communication

5. Basic principles of on-call

Section 2: Common Topics

1. Meningitis and meningism

2. Gastrointestinal infection

3. Community acquired pneumonia

4. Rash in pregnancy

5. Rash and fever in children

6. Illness in returning travellers

7. Jaundice

8. Infection in the immunosuppressed

Section 3: Diseases

1. Amoebic dysentery

2. Anthrax

3. Bacillus cereus

4. Botulism

5. Brucellosis

6. Campylobacter

7. Chickenpox and shingles

8. Chikungunya

9. Chlamydia pneumoniae

10. Chlamydia trachomatis

11. Cholera

12. CJD and other Human TSEs

13. Clostridium difficile

14. Clostridium perfringens

15. Coronavirus (including MERS and SARS)

16. Cryptosporidiosis

17. Cyclosporiasis

18. Cytomegalovirus

19. Dengue fever

20. Diphtheria

21. Enterococci (including GRE)

22. Enterovirus infections (including hand, foot and mouth disease)

23. Epstein-Barr virus

24. Giardiasis

25. Gram-negative bacteraemias (including Carbapenem resistant enterobacteriaceae)

26. Gonorrhoea, syphilis and other acute STIs

27. Hantavirus

28. Headlice

29. Helicobacter pylori

30. Hepatitis A

31. Hepatitis B

32. Hepatitis C

33. Hepatitis, delta

34. Hepatitis E

35. Herpes simplex

36. Haemophilus influenza type b (Hib)

37. HIV

38. Influenza

39. Japanese B encephalitis

40. Legionellosis

41. Leprosy

42. Leptospirosis

43. Listeriosis

44. Lyme disease

45. Malaria

46. Measles

47. Meningococcal infection

48. MRSA

49. Mumps

50. Mycoplasma pneumoniae infection

51. Norovirus

52. Paratyphoid fever

53. Parvovirus B19 (fifth disease)

54. Plague

55. Pneumococcal infection

56. Poliomyelitis

57. Psittacosis

58. Q fever

59. Rabies

60. Relapsing fever

61. Respiratory syncytial virus (RSV)

62. Ringworm

63. Rotavirus

64. Rubella

65. Salmonellosis

66. Scabies

67. Schistosomiasis

68. Shigellosis

69. Shiga-toxin producing E. coli (STEC) and other diarrhoeagenic E. coli

70. Smallpox

71. Staphylococcal food poisoning

72. Streptococcal infections

73. Tetanus

74. Threadworms

75. Tick-borne encephalitis

76. Toxocariasis

77. Toxoplasmosis

78. Tuberculosis (and non-tuberculous mycobacteria)

79. Tularaemia

80. Typhoid fever

81. Vibrio parahaemolyticus

82. Viral haemorrhagic fevers (including Ebola)

83. Warts & verrucae (and Molluscum contagiosum)

84. West Nile virus

85. Whooping cough (pertussis)

86. Yellow fever

87. Yersiniosis

88. Zika virus

89. Other organisms

1. Bacteria

2. Rickettsia

3. Viruses

4. Protozoa

5. Helminths

6. Fungi

7. Bites, stings and venoms

8. Chemical food-borne illness

Section 4: Services and Organisations

1. Surveillance of Communicable Disease

2. Managing infectious disease incidents and outbreaks

3. Community infection control

4. Hospital infection control

5. Antimicrobial stewardship

6. Risks to & from healthcare workers

7. Co-ordination if immunisation services

8. Co-ordination of sexual health services

9. Prevention of blood-borne viral infection

10. Co-ordination of services for tuberculosis control

11. Travel Health

12. Migrant and refugee health

13. Emergency preparedness planning and response

14. Non-infectious environmental hazards

15. Managing acute chemical incidents

16. Managing acute radiation incidents

17. Deliberate release of biological, chemical or radiological hazards

18. Clinical governance and audit

19. Global health security

Section 5: Communicable Disease Control in Europe

1. WHO and the International Health Regulations

2. International collaboration in Europe

3. National Example: Administrative arrangements for health protection in England

4. Austria

5. Belgium

6. Bulgaria

7. Croatia

8. Cyprus

9. Czech Republic

10. Denmark

11. Estonia

12. Finland

13. France

14. Germany

15. Greece

16. Hungary

17. Iceland

18. Republic of Ireland

19. Italy

20. Latvia

21. Lithuania

22. Luxemburg

23. Malta

24. Netherlands

25. Norway

26. Poland

27. Portugal

28. Romania

29. Slovakia

30. Slovenia

31. Spain

32. Sweden

33. Switzerland

34. United Kingdom

Appendix: Guidance documents

Other useful websites

Jeremy Hawker is Consultant Epidemiologist in the Field Service of Public Health England’s National Infection Service and honorary Professor at the Universities of Liverpool, Warwick and Staffordshire. Norman Begg is an independent vaccine consultant who has worked in public health and the pharmaceutical industry and former Chief Medical Officer, GlaxoSmithKline Biologicals, Wavre, Belgium. Ralf Reintjes is Professor of Epidemiology and Public Health Surveillance, Hamburg, Germany and Adjunct Professor of Infectious Disease Epidemiology, Tampere, Finland. Karl Ekdahl is Head of Public Health Capacity and Communication Unit, European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden. Obaghe Edeghere is Consultant Epidemiologist for the Field Service of Public Health England’s National Infection Service, UK. Jim van Steenbergen is an an independent consultant in communicable disease control and former National Coordinator for Communicable Disease Control, Centre for Infectious Disease Control at the National Institute for Public Health and the Environment, Netherlands